Boston Scientific Merger
Boston Scientific is pleased to announce that its merger with Guidant is complete. By combining two great companies, we've created a global leader in cardiovascular devices as well as a broad and diverse medical device company with total anticipated revenue of nearly $9 billion in 2006. Boston Scientific has also completed an agreement with Abbott under which Abbott will acquire Guidant's vascular intervention and endovascular businesses, while agreeing to share rights to Guidant's drug-eluting stent program.
The new Boston Scientific will provide clinicians with an unparalleled breadth of products, a proven record of research and clinical science, and the promising future of a pipeline that will continue to provide leading technologies tomorrow and beyond. The merger brings together two companies with a proud heritage of health care innovation, a powerful, shared purpose and a workforce that is the most talented, dedicated and innovative in the industry.
